Tech Company Financing Transactions

Arcxis Biotechnologies Funding Round

Claremont Creek Ventures and Kaiser Permanente Ventures invested in a $1.4 million funding round for Arcxis Biotechnologies. The round was announced on 6/30/2010.

Transaction Overview

Announced On
6/30/2010
Transaction Type
Venture Equity
Amount
$1,440,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6920 Koll Center Pkwy. 215
Pleasanton, CA 94566
USA
Email Address
Overview
Arcxis Biotechnologies is focused on developing elegant, integrated and compact solutions to molecular diagnostic challenges.
Profile
Arcxis Biotechnologies LinkedIn Company Profile
Social Media
Arcxis Biotechnologies Company Twitter Account
Company News
Arcxis Biotechnologies News
Facebook
Arcxis Biotechnologies on Facebook
YouTube
Arcxis Biotechnologies on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Christine Meda
  Christine Meda LinkedIn Profile  Christine Meda Twitter Account  Christine Meda News  Christine Meda on Facebook
Chief Technical Officer
Jay West
  Jay West LinkedIn Profile  Jay West Twitter Account  Jay West News  Jay West on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/30/2010: Calistoga Pharmaceuticals venture capital transaction
Next: 6/30/2010: Biomimedica venture capital transaction

 

Share this article

 


About Database of VC Transactions

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary